Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 EUR | 0.00% |
|
+3.25% | +103.20% |
04-26 | Labiana Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2022 | Labiana Health, S.A. acquired 10.31% stake in Trichome Pharma. | CI |
Sales 2024 * | 66M 70.74M 5.58B | Sales 2025 * | 72M 77.17M 6.09B | Capitalization | 17.94M 19.22M 1.52B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 1M 1.07M 84.55M | EV / Sales 2024 * | 0.8 x |
Net Debt 2024 * | 35M 37.51M 2.96B | Net Debt 2025 * | 35M 37.51M 2.96B | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
127
x | P/E ratio 2025 * |
13
x | Employees | 433 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.88% |
1 week | +3.25% | ||
Current month | +13.39% | ||
1 month | +41.11% | ||
3 months | +58.75% | ||
6 months | +133.03% | ||
Current year | +103.20% |
![Extreme 2.38](/images/extremecours_fleche.png)
![Extreme 1.75](/images/extremecours_fleche.png)
![Extreme 1.18](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Miquel Pujolriu
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
18/06/24 | 2.54 | 0.00% | 500 |
17/06/24 | 2.54 | 0.00% | 0 |
14/06/24 | 2.54 | +0.79% | 1,722 |
13/06/24 | 2.52 | +5.88% | 700 |
12/06/24 | 2.38 | -3.25% | 3,507 |
Delayed Quote BME, June 18, 2024 at 09:07 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+103.20% | 19.23M | |
-13.41% | 77.98B | |
+22.35% | 9.01B | |
+23.12% | 3.64B | |
+12.67% | 1.65B | |
-5.08% | 1.23B | |
-30.18% | 1.16B | |
-31.11% | 1.15B | |
-23.45% | 999M | |
-11.41% | 926M |
- Stock Market
- Equities
- LAB Stock